Price$7.40+0.08 (+1.09%)
2026-03-042026-06-05
News · 26 weeks56-89%
2025-12-142026-06-07
Mix4190d
- Insider25(61%)
- SEC Filings7(17%)
- Other5(12%)
- Offering2(5%)
- Earnings1(2%)
- Analyst1(2%)
Latest news
25 items- ANALYSTGoldman initiated coverage on LifeStance Health Group with a new price targetGoldman initiated coverage of LifeStance Health Group with a rating of Neutral and set a new price target of $9.00
- SECSEC Form 8-K filed by LifeStance Health Group Inc.8-K - LifeStance Health Group, Inc. (0001845257) (Filer)
- INSIDERDirector Shuey Eric sold $1,951,763 worth of shares (243,362 units at $8.02) (SEC Form 4)4 - LifeStance Health Group, Inc. (0001845257) (Issuer)
- INSIDERDirector Black Darren M. sold $47,315,281 worth of shares (5,899,661 units at $8.02) (SEC Form 4)4 - LifeStance Health Group, Inc. (0001845257) (Issuer)
- INSIDERDirector Bessler Robert sold $4,611,773 worth of shares (575,034 units at $8.02) (SEC Form 4)4 - LifeStance Health Group, Inc. (0001845257) (Issuer)
- INSIDERLarge owner Tpg Gp A, Llc sold $226,821,183 worth of shares (28,281,943 units at $8.02) (SEC Form 4)4 - LifeStance Health Group, Inc. (0001845257) (Issuer)
- SECSEC Form 8-K filed by LifeStance Health Group Inc.8-K - LifeStance Health Group, Inc. (0001845257) (Filer)
- INSIDERDirector Bessler Robert sold $641,250 worth of shares (75,000 units at $8.55) (SEC Form 4)4 - LifeStance Health Group, Inc. (0001845257) (Issuer)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by LifeStance Health Group Inc.SCHEDULE 13G/A - LifeStance Health Group, Inc. (0001845257) (Subject)
- SECSEC Form 424B7 filed by LifeStance Health Group Inc.424B7 - LifeStance Health Group, Inc. (0001845257) (Filer)
- PRLifeStance Health Group Announces Pricing of Secondary Public OfferingSCOTTSDALE, Ariz., May 07, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. ("LifeStance" or the "Company") (NASDAQ:LFST), one of the nation's largest providers of virtual and in-person outpatient mental health care, today announced the pricing of a secondary underwritten public offering of 35,000,000 shares of LifeStance's common stock, par value $0.01 per share (the "Common Stock") at a public offering price of $8.15 per share, pursuant to a shelf registration statement filed with the Securities and Exchange Commission (the "SEC") from certain stockholders of the Company (the "Selling Stockholders"). The Selling Stockholders will receive all of the proceeds from the offering. The C
- PRLifeStance Health Group Announces Launch of Secondary Public OfferingSCOTTSDALE, Ariz., May 07, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. ("LifeStance" or the "Company") (NASDAQ:LFST), one of the nation's largest providers of virtual and in-person outpatient mental health care, today announced that pursuant to a shelf registration statement filed with the Securities and Exchange Commission (the "SEC"), certain stockholders of the Company (the "Selling Stockholders") intend to offer 35,000,000 shares of LifeStance's common stock, par value $0.01 per share (the "Common Stock"). The Selling Stockholders will receive all of the proceeds from the offering. The Company is not selling any shares of Common Stock in the offering and will not receive any
- SECSEC Form 10-Q filed by LifeStance Health Group Inc.10-Q - LifeStance Health Group, Inc. (0001845257) (Filer)
- SECLifeStance Health Group Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits8-K - LifeStance Health Group, Inc. (0001845257) (Filer)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by LifeStance Health Group Inc.SCHEDULE 13G/A - LifeStance Health Group, Inc. (0001845257) (Subject)
- PRLifeStance to Present at Upcoming Investor ConferencesSCOTTSDALE, Ariz., April 29, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ:LFST), one of the nation's largest providers of outpatient mental healthcare, today announced that management will present at the following upcoming investor conferences. Bank of America 2026 Healthcare Conference:Presenter: Dave Bourdon, CEODate: Wednesday, May 13, 2026Location: Encore at the Wynn, Las Vegas, NVTime: 5:00 p.m. (Pacific Time) William Blair 46th Annual Growth Stock ConferencePresenter: Dave Bourdon, CEODate: Thursday, June 4, 2026Location: Loews Chicago Hotel, Chicago, ILTime: 11:20 a.m. (Central Time) The presentations will be webcast live and will be available on the Events and
- INSIDERDirector Bessler Robert sold $492,400 worth of shares (69,899 units at $7.04) (SEC Form 4)4 - LifeStance Health Group, Inc. (0001845257) (Issuer)
- INSIDERDirector Bessler Robert sold $35,758 worth of shares (5,101 units at $7.01) (SEC Form 4)4 - LifeStance Health Group, Inc. (0001845257) (Issuer)
- SECSEC Form DEFA14A filed by LifeStance Health Group Inc.DEFA14A - LifeStance Health Group, Inc. (0001845257) (Filer)
- SECSEC Form DEF 14A filed by LifeStance Health Group Inc.DEF 14A - LifeStance Health Group, Inc. (0001845257) (Filer)
- PRLifeStance to Host First Quarter 2026 Earnings Conference Call on May 7, 2026SCOTTSDALE, Ariz., April 16, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ:LFST), one of the nation's largest providers of outpatient mental health care, will issue its first quarter 2026 earnings release before the market opens on Thursday, May 7, 2026. LifeStance will host a live earnings conference call to discuss first quarter results on May 7, 2026, at 8:30 a.m. Eastern Time. To participate in the call, please dial 1-800-715-9871, domestically, or 1-646-307-1963, internationally, and use conference ID 8795477, or ask to be joined into the LifeStance call. A real-time audio webcast can be accessed via the Events and Presentations section of the LifeStance Investor Re
- PRLifeStance Publishes Outcomes Data Validating the Benefit of Mental Health Treatment at ScaleAnalysis of 180,000 Patients Validates Measurement-Informed Care for Anxiety and DepressionSCOTTSDALE, Ariz., April 9, 2026 /PRNewswire/ -- LifeStance Health, one of the nation's largest providers of outpatient mental health care, published new clinical outcomes data demonstrating that LifeStance patients treated for anxiety and depression broadly experienced clinically significant improvements in their symptoms. The analysis included nearly 180,000 patients who initiated care between September 2024 and December 2025 across the 33 states LifeStance serves. Key findings include:A
- INSIDERSEC Form 4 filed by Pardo Ryan4 - LifeStance Health Group, Inc. (0001845257) (Issuer)
- INSIDERSEC Form 4 filed by Mcgroarty Ryan4 - LifeStance Health Group, Inc. (0001845257) (Issuer)
- INSIDERSEC Form 4 filed by Mcgroarty Ryan4 - LifeStance Health Group, Inc. (0001845257) (Issuer)
LFST FAQ
7 questionsWhat does LifeStance Health Group Inc. do?
LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics. It offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. The company offers patients care virtually through its online delivery...Where does LFST stock trade?
LifeStance Health Group Inc. (LFST) is listed on NASDAQ.What sector and industry is LFST in?
LifeStance Health Group Inc. operates in the Health Care sector, Medical/Nursing Services industry.When did LifeStance Health Group Inc. go public?
LifeStance Health Group Inc. (LFST) completed its IPO in 2021.What are analysts saying about LFST?
LifeStance Health Group Inc. has had 8 recent analyst actions on file. The most recent action was from Goldman: Neutral with a $900.00 price target on 2026-06-05. Recent price targets range from $800.00 to $1000.00.What companies are similar to LFST?
Notable peers in the same industry include BTSG (BrightSpring Health Services Inc.), HIMS (Hims & Hers Health Inc.), CHE (Chemed Corp), AMED (Amedisys Inc), LHCG (LHC Group). Compare LFST side-by-side with any of them on Quantisnow.How can I track LFST on Quantisnow?
Quantisnow aggregates LifeStance Health Group Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow LFST to receive live email and push alerts on every new disclosure.